NVAX 8-K 2026-01-12

NOVAVAX INC (NVAX) 8-K dated 2026-01-12 — accession 0001104659-26-002725. This URL is the filing, not the NVAX hub.

NOVAVAX INC (NVAX) is a biotechnology company listed on US.

NOVAVAX INC filed a 8-K on 2026-01-12. Accession 0001104659-26-002725.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B.

Not investment advice. The NVAX SEC hub lists recent forms. The stock page is the research view.